SCHEMBL2576303

SCHEMBL2576303

NC(=O)CCCCC(S)CCS.[Zn]

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ENPEP Q07075 4/20 0.38
ANPEP P15144 1/20 0.36
GSTK1 Q9Y2Q3 2/20 0.35
KMT2A Q03164 2/20 0.34
ALOX15 P16050 1/20 0.34
BLM P54132 1/20 0.34
PMP22 Q01453 1/20 0.34
FOLH1 Q04609 5/20 0.33
RNPEP Q9H4A4 1/20 0.32
MEN1 O00255 1/20 0.31
FAAH O00519 1/20 0.31
TP53 P04637 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C19 P33261 1/20 0.31
SOAT1 P35610 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL37411 0.98 ENPEP (0.39) ENPEPANPEPGSTK1KMT2AALOX15
SCHEMBL3338585 0.88 TP53 (0.33) ENPEPANPEPKMT2AMEN1FAAH
SCHEMBL3277681 0.86 TP53 (0.33) ENPEPANPEPGSTK1KMT2AMEN1
SCHEMBL3278910 0.84 TP53 (0.33) ENPEPANPEPKMT2AMEN1FAAH
SCHEMBL3277556 0.84 TP53 (0.33) ENPEPANPEPKMT2AMEN1FAAH
Dihydrolipoic Acid SCHEMBL2582098 0.83 FOLH1 (0.54) ENPEPANPEPGSTK1PMP22FOLH1
Hexanoate SCHEMBL3278765 0.83 FFAR4 (0.51) ENPEPKMT2AALOX15MEN1
Dihydrolipoic Acid SCHEMBL4761911 0.82 FOLH1 (0.52) ENPEPANPEPGSTK1PMP22FOLH1
Dihydrolipoic Acid SCHEMBL618576 0.81 FOLH1 (0.56) ENPEPANPEPGSTK1PMP22FOLH1
Dihydrolipoic Acid SCHEMBL1115003 0.81 FOLH1 (0.56) ENPEPANPEPGSTK1PMP22FOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8048911-B2 Melanin eliminator preparation OGA Research, Inc. (JP) 2011-11-01 US disclosed
US-20090093541-A1 MELANIN ELIMINATOR PREPARATION OGA RESEARCH, INC (JP) 2009-04-09 US disclosed
CN-100367949-C Melanin extinguisher OGA RES INC (JP) 2008-02-13 CN disclosed
US-20060122100-A1 Melanin extinguisher OGA RESEARCH, INCORPORATED (JP) 2006-06-08 US disclosed
CN-1681490-A Melanin extinguisher OGA RES INC (JP) 2005-10-12 CN disclosed
EP-1547590-A1 MELANIN EXTINGUISHER Oga Research, Incorporated (JP) 2005-06-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122100-A1 Melanin extinguisher TYR, MC1R, MITF ENPEP 314/4885ANPEP 92/4885GSTK1 2911/4885
US-20090093541-A1 MELANIN ELIMINATOR PREPARATION TYR, MC1R, MCHR1 ENPEP 129/4885ANPEP 47/4885GSTK1 3045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.